information for new investors, page-137

re: up via the escalator down via the window Cromagnon Man,

Novogen has a very solid pipeline of drugs, some in Phase II trials, some completed trials awaiting commercialisation and some in the market place now with Patent Protection. They also have the backing of some very reputable institutions which are extreamly excited over the pipeline of drugs.

While NRT has had a good run, read back at the posts Gerry and I have been posting and you'll soon see the inherent value in Novogen. Do your research on this stock as the upside run has only just begun. I still think this will be Australias biggest company in the not too distant future.

Cheers,
Munch.